Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Disease

Liver cancer detection system from Japan to debut

A world-leading system developed in Japan to detect liver cancer is to be introduced in Thailand, where the disease is a major health issue.

Bangkok Post

Adolescents aged 12 to 15 at risk of severe disease able to get COVID-19 booster after government accepts latest ATAGI advice

Australian teenagers aged 12-15 who are at risk of severe disease will be able to receive a COVID-19 booster shot from as early as next week.

ABC News

Scientists want to know whether meningococcal B vaccines could protect against gonorrhoea

The vaccine against the B strain is not available to most children and adolescents free of charge but a researcher says new trials could change its cost-effectiveness.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

Mystery as ‘sickly’ Vladimir Putin suddenly postpones annual TV Q&A amid health rumours

The Russian president pulled out of the annual event which has fuelled speculation he is battling cancer or early stage Parkinson’s disease with a new date yet to be announced

Daily Mirror

How did monkeypox emerge in the US when the first diagnosed patient hadn’t left the country?

When a local man arrived in a Boston emergency department on May 12 with an unusual mix of symptoms, doctors were scratching their heads for days.

ABC News

Exclusive: Anthony Fauci on the Aids crisis, monkeypox, trans rights and his retirement (OLD)

In an exclusive interview with Io Dodds, Dr Anthony Fauci looks back on his decades-long career in public health

The Independent UK

Vertex Pharma Gains FDA Breakthrough Therapy Designation For Kidney Disease Drug

Vertex Pharmaceuticals (NASDAQ: VRTX) received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate inaxaplin (VX-147) for the treatment of patients with APOL1-mediated focal segmental glomerulosclerosis (FSGS).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Blue Cross advice on monkeypox after patients warned to 'stay away from pets'

The UK Health Security Agency (UKHSA) has confirmed a total of 321 monkeypox cases in the UK, as of June 7, with 305 in England, 11 in Scotland, three in Wales and two in Northern Ireland

Daily Mirror

Precision BioSciences Highlights Interim Data From Allogeneic CAR T Programs In Blood Cancer Patients

Precision BioSciences Inc (NASDAQ:DTIL) shared new interim data from the Phase 1/2a study of PBCAR0191 for the patient population with aggressive lymphomas. The data demonstrated that PBCAR0191 produced high clinical response rates in CAR T relapsed patients who received a median of five prior lines of therapy. Evaluable subjects in the study had…

Benzinga

Stealth Bio Shares Trading Higher On Pre-Clinical Presentation Of Neuromuscular Disease Candidate

Stealth BioTherapeutics (NASDAQ: MITO) presented Pre-Clinical clinical results of SBT-272 for patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) at the Keystone Neurodegeneration Symposium in Keystone, held June 5-9, 2022.

Benzinga

Why Aldeyra Therapeutics' Shares Are Soaring Today?

Aldeyra Therapeutics Inc's (NASDAQ:ALDX) Phase 3 TRANQUILITY-2 trial of reproxalap for dry eye disease has achieved the primary endpoint. Reproxalap was statistically superior to the vehicle for each of the two prespecified primary endpoints, Schirmer test and ≥10 mm Schirmer test responder proportions after a single day of dosing. The Schirmer test,…

Benzinga

Immunovant To Start Pivotal Batoclimab Trials In Thyroid Eye Disease Later This Year

Immunovant Inc (NASDAQ:IMVT) has aligned with the FDA Division of Ophthalmology on plans to initiate two placebo-controlled Phase 3 trials to evaluate batoclimab in thyroid eye disease (TED). Immunovant expects to initiate its Phase 3 TED program in 2H of 2022 and is expected to enroll about 100 subjects for each trial. Topline…

Benzinga

No, Latinos don't actually have less heart disease – a new large study refutes the longstanding 'Latino paradox'

The Research Brief is a short take about interesting academic work.

The Conversation

An egg a day helps lower risk of heart disease, according to This Morning expert

An expert doctor on This Morning has shared research on ITV's This Morning that says eating one egg a day could help us lower the risk of developing heart disease

Daily Mirror

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Mirror

Elderly people with conditions like arthritis could claim an extra £369 from DWP

Attendance Allowance is a benefit designed to help cover your costs if you have a disability severe enough that you need someone to help look after you - here's how it works

Daily Mirror

'I've dodged Covid for years but caught monkeypox at superspreading Spanish sauna'

George, who is not using his real name, said he first noticed a black, scabby lesion in May and it he ended up spending three weeks at the Royal Free Hospital in the infectious disease ward

Bangkok Post

Anutin: Time to 'move on', declare Covid-19 endemic

Public Health Minister Anutin Charnvirakul on Wednesday declared his ministry's determination to "move on", to downgrade Covid-19 to an endemic disease and allow people to return to a normal life, but did not give a definite time frame.

Daily Mirror

Sleeping position could trigger conditions like Motor neurone disease, study claims

The position you sleep in can impact the risk of developing neurodegenerative diseases like ALS, a study recently published in BioMed Central found

Get all your
news in one place.

100's of premium titles.
One news app.

Manchester Evening News

Monkeypox cases found in the North West as disease climbs

A senior Greater Manchester health source has warned that 'technically we are all at risk' as monkeypox does not just affect 'certain cohorts of the population'

The Conversation

Parkinson’s disease: bad dreams could be an early warning sign – new study

Every night when we go to sleep, we spend a couple of hours in a virtual world created by our brains in which we are the main protagonist of an unfolding story we did not consciously create. In other words, we dream.

The Independent UK

Monkeypox signs and symptoms: What to look for and how it spreads

Tropical disease originating in Africa has spread across the world since May

Dublin Live

Key sign you may be developing Parkinson's disease identified in new study

Experts from the University of Birmingham think there is evidence that regular bad dreams could be an early warning sign for developing the condition

Daily Record

Monkeypox designated a 'notifiable disease' as UK ramps up response

The UK Health Security Agency (UKHSA) said laboratories must also tell it if the virus is identified in a sample.

Daily Mirror

Regular nightmares could be a sign of Parkinson’s disease according to new study

A study of 3,818 men aged 67 or over found that those experiencing frequent bad dreams during the first five years were more than three times as likely to develop Parkinson’s

Tribune News Service

Missouri woman says she caught STD in car. Auto insurance to pay out $5.2 million

KANSAS CITY, Mo. — The Missouri Court of Appeals has affirmed that an insurance company must pay a $5.2 million settlement granted to a Jackson County woman who claimed she unwittingly caught a sexually transmitted disease from her former romantic partner in his car.

1 … 541 542 543 544

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

509 stories

Blue Cross

124 stories

University of Birmingham

Vertex Pharmaceuticals

58 stories

Massachusetts General Hospital

Precision BioSciences

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.